Tarsus Pharmaceuticals
TARS
TARS
202 hedge funds and large institutions have $1.87B invested in Tarsus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 85 increasing their positions, 49 reducing their positions, and 29 closing their positions.
Holders
202
Holders Change
+11
Holders Change %
+5.76%
% of All Funds
2.71%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
44
Increased
85
Reduced
49
Closed
29
Calls
$417K
Puts
–
Net Calls
+$417K
Net Calls Change
-$347K
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$73.2M |
| 2 |
2
BlackRock
New York
|
$154M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$19.1M |
| 4 |
4
ClearBridge Investments
New York
|
$18M |
| 5 |
PBA
5
Paradigm Biocapital Advisors
New York
|
$121M |
Top Sellers
| 1 |
1
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
$40.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$9.29M |
| 3 |
O
3
OrbiMed
New York
|
$8.02M |
| 4 |
GGHC
4
Gilder Gagnon Howe & Co
New York
|
$3.13M |
| 5 |
5
Lord, Abbett & Co
Jersey City,
New Jersey
|
$40.3M |
